Latest filing published 04 Nov 2013 for VAXGEN INC.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Burrill Life Sciences Capital Fund LP on record concern Vaxgen Inc. Over a trading history stretching from 21 January 2011 to 30 October 2013, the count stands at 12 filings.
Every open-market trade on record is a purchase: 7 purchases worth €64k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €4,351.
The newest entry dates from 4 November 2013: a transaction, in Vaxgen Inc. The clock since the last published purchase (18 February 2011) now reads 5,727 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 13 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations